MENU
ZBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Zenas Biopharma (ZBIO) Ownership - Who owns Zenas Biopharma?
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
331.47M
P/E Ratio
N/A
Total Cash
350.77M
Projected Growth
N/A
Total Debt
1M
Revenue
5M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
8.39
Total Debt/Equity
N/A
Revenue/Share
0.38 USD as % of share price
Fundamentals
ZBIO
Capitalization
331M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
351M
Total Cash/Share
8.39
Total Debt
1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.38%
Revenue
5M
ROE
N/A
Book Value
312M
P/B Ratio
1.06
Cash Flow
N/A
Earnings
-11.89
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
6.21
Current Revenue Per Employee
38461.54
Dividends Per Share - Security
N/A
EBITDA
-163.75M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-71.66
Shares Held By Institutions
319M
Shares Outstanding - Current
41.8M
Total Liabilities
57.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-3.175
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information